Nurix Therapeutics, Inc. (NRIX): Weighted Average Diluted Shares
86.67M
Year ended 2025-11-30
+21.3%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-11-30 | 86.67M | +29.1% | 2026-01-28, From 2024-12-01 |
| 2024-11-30 | 67.12M | +23.5% | 2026-01-28, From 2023-12-01 |
| 2023-11-30 | 54.34M | +11.8% | 2026-01-28, From 2022-12-01 |
| 2022-11-30 | 48.61M | +13.3% | 2025-01-28, From 2021-12-01 |
| 2021-11-30 | 42.90M | n/a | 2023-02-09, From 2020-12-01 |